Ribeiro Júnior H, Ribeiro T, Mattos A, Palmeira C, Fernandez D, Sant'Ana I, Rodrigues I, Bendicho M T, Fontaine O
Department of Pediatrics, Federal University of Bahia School of Medicine, Brazil.
J Am Coll Nutr. 1994 Jun;13(3):251-5. doi: 10.1080/07315724.1994.10718405.
In a randomized, double-blind, controlled clinical trial we compared the efficacy of adding 90 mmol/L L-glutamine to the standard World Health Organization oral rehydration salts (WHO-ORS).
One hundred twenty male infants, > 1 month and < 1 year of age, with acute non-cholera diarrhea and dehydration were randomly assigned to one of the two treatment groups.
Patients were kept in a metabolic unit where body weight, ORS, water and food intake, as well as stool, urine and vomitus output were recorded at 6-hour intervals. Laboratory evaluation, including blood gases and electrolytes, were monitored during hospitalization.
Diarrheal stool output, duration of diarrhea and volume of ORS required to achieve and maintain hydration was not significantly different between the treatment groups.
This study demonstrated that a glutamine-based ORS did not provide any additional therapeutic advantage over the standard WHO-ORS during treatment of dehydration in infants with acute non-cholera diarrhea.
在一项随机、双盲、对照临床试验中,我们比较了在标准世界卫生组织口服补液盐(WHO-ORS)中添加90毫摩尔/升L-谷氨酰胺的疗效。
120名年龄大于1个月且小于1岁、患有急性非霍乱性腹泻和脱水的男婴被随机分配到两个治疗组之一。
患者被安置在一个代谢病房,每隔6小时记录体重、ORS、水和食物摄入量以及粪便、尿液和呕吐物排出量。住院期间监测包括血气和电解质在内的实验室评估。
治疗组之间的腹泻粪便排出量、腹泻持续时间以及实现和维持水合所需的ORS量没有显著差异。
本研究表明,在治疗急性非霍乱性腹泻婴儿脱水时,基于谷氨酰胺的ORS相比标准WHO-ORS没有提供任何额外的治疗优势。